hydroxyindoleacetic acid has been researched along with Tremor in 32 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to examine the influence of a unilateral 6-hydroxydopamine (6-OHDA)-induced partial lesion of both the substantia nigra pars compacta (SNc, A9) and retrorubral field (RRF, A8) on the tremor evoked by harmaline." | 7.78 | 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats. ( Berghauzen, K; Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Schulze, G, 2012) |
| "The purpose of this study was to correlate the chlordecone-elicited tremor activity with alterations of brain neurotransmitters." | 7.67 | Effects of chlordecone exposure on brain neurotransmitters: possible involvement of the serotonin system in chlordecone-elicited tremor. ( Gerhart, J; Hong, JS; Tilson, HA; Uphouse, LL; Wilson, WE, 1984) |
| "The relationships between behavioral responses and levels of serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in brain of mice were investigated after intravenous injection of fumitremorgin A (FTA)." | 7.66 | Biochemical investigation on the abnormal behaviors induced by fumitremorgin A, a tremorgenic mycotoxin to mice. ( Ozaki, N; Suzuki, S; Yamazaki, M, 1983) |
| "Alterations of steady state and metabolism of putative neurotransmitters were studied in the brain of rats with a sustained tremor evoked by nicotine and pilocarpine." | 7.66 | Possible mechanisms of sustained tremor induction by nicotine in pilocarpine treated animals. ( Dohi, T; Tsujimoto, A, 1978) |
| "Tremor is the second most common neurological adverse effect in patients receiving treatment with SSRIs." | 5.32 | Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats. ( Al Deeb, S; Al Kadasah, S; Al Moutaery, K; Arshaduddin, M; Biary, N; Tariq, M, 2004) |
| "The aim of the present study was to examine the influence of a unilateral 6-hydroxydopamine (6-OHDA)-induced partial lesion of both the substantia nigra pars compacta (SNc, A9) and retrorubral field (RRF, A8) on the tremor evoked by harmaline." | 3.78 | 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats. ( Berghauzen, K; Kolasiewicz, W; Kuter, K; Nowak, P; Ossowska, K; Schulze, G, 2012) |
| "The administration of veratramine produced generalized tremor, myoclonus, hindlimb abduction, backward gait and Straub tail, similar to the "5-hydroxytryptamine (5-HT) syndrome", in mice." | 3.68 | Veratramine-induced behavior associated with serotonergic hyperfunction in mice. ( Izumi, K; Nagata, R, 1991) |
| "The purpose of this study was to correlate the chlordecone-elicited tremor activity with alterations of brain neurotransmitters." | 3.67 | Effects of chlordecone exposure on brain neurotransmitters: possible involvement of the serotonin system in chlordecone-elicited tremor. ( Gerhart, J; Hong, JS; Tilson, HA; Uphouse, LL; Wilson, WE, 1984) |
| "The relationships between behavioral responses and levels of serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) in brain of mice were investigated after intravenous injection of fumitremorgin A (FTA)." | 3.66 | Biochemical investigation on the abnormal behaviors induced by fumitremorgin A, a tremorgenic mycotoxin to mice. ( Ozaki, N; Suzuki, S; Yamazaki, M, 1983) |
| "Alterations of steady state and metabolism of putative neurotransmitters were studied in the brain of rats with a sustained tremor evoked by nicotine and pilocarpine." | 3.66 | Possible mechanisms of sustained tremor induction by nicotine in pilocarpine treated animals. ( Dohi, T; Tsujimoto, A, 1978) |
| "Amantadine-induced tremor has been investigated using mice." | 3.65 | Amantadin e tremor, a 5-hydroxytryptamine-mediated response? ( Cox, B; Tha, SJ, 1975) |
| "Oxotremorine did not alter the level of 5-HT and 5-hydroxyindoleacetic acid in different brain regions." | 3.65 | Serotonin content in the central nervous system of rats and cholinergic tremor. ( Funk, KF; Oelszner, W; Staib, AH; Westermann, KH, 1975) |
| "A single dose of p-chloroamphetamine, 10 mg per kilogram, produced postural abnormalities, tremor, myoclonus, and autonomic signs in rats 5 minutes after intraperitoneal injection." | 3.65 | Postural changes, tremor, and myoclonus in the rat immediately following injections of p-chloromaphetamine. ( Growdon, JH, 1977) |
| "We have studied the urinary excretion of 1,4-methylhistamine (1,4-MeHm), 5-hydroxyindole-3-acetic acid (5-HIAA) and homovanillic acid (HVA) in patients with Parkinson's disease, choreiform movements and essential tremor." | 3.65 | Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa. ( Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ, 1977) |
| " High doses of clorgyline, a selective inhibitor MAO-A, produced a characteristic stereotyped syndrome of hypermotility and tremor as well as an increase in apparent 5-HT and a decrease in apparent 5-HIAA in brain." | 3.65 | The inhibition of A and B forms of MAO in the production of a characteristic behabioural syndrome in rats after 1-tryptophan loading. ( Lassen, JB; Squires, RF, 1975) |
| " The effect of chronic ACTH treatment on 5-HT(2) receptor and 5-HT(2A)-receptor mRNA levels was not altered by the chronic administration of imipramine." | 1.35 | Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex. ( Akiyama, K; Fujitani, Y; Gomita, Y; Kanzaki, H; Kawasaki, H; Kimoto, S; Kitagawa, K; Kitamura, Y; Ouchida, M; Sendo, T; Shibata, K; Shimizu, K, 2008) |
| "Tremor is the second most common neurological adverse effect in patients receiving treatment with SSRIs." | 1.32 | Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats. ( Al Deeb, S; Al Kadasah, S; Al Moutaery, K; Arshaduddin, M; Biary, N; Tariq, M, 2004) |
| "Pretreatment with phenytoin significantly attenuated the tremor produced by p,p'-DDT but enhanced that produced by chlordecone." | 1.27 | 5,5-Diphenylhydantoin antagonizes neurochemical and behavioral effects of p,p'-DDT but not of chlordecone. ( Hong, JS; Hudson, PM; Tilson, HA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (65.63) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 4 (12.50) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolasiewicz, W | 1 |
| Kuter, K | 1 |
| Berghauzen, K | 1 |
| Nowak, P | 1 |
| Schulze, G | 1 |
| Ossowska, K | 1 |
| Okamoto, R | 1 |
| Itoh, Y | 1 |
| Murata, Y | 1 |
| Kobayashi, D | 1 |
| Hosoi, M | 1 |
| Mine, K | 1 |
| Ricaurte, GA | 1 |
| Yuan, J | 1 |
| Hatzidimitriou, G | 1 |
| Cord, BJ | 1 |
| McCann, UD | 1 |
| Mehta, H | 1 |
| Saravanan, KS | 1 |
| Mohanakumar, KP | 2 |
| Arshaduddin, M | 1 |
| Al Kadasah, S | 1 |
| Biary, N | 1 |
| Al Deeb, S | 1 |
| Al Moutaery, K | 1 |
| Tariq, M | 1 |
| Kitamura, Y | 1 |
| Shibata, K | 1 |
| Akiyama, K | 1 |
| Kimoto, S | 1 |
| Fujitani, Y | 1 |
| Kitagawa, K | 1 |
| Kanzaki, H | 1 |
| Ouchida, M | 1 |
| Shimizu, K | 1 |
| Kawasaki, H | 1 |
| Sendo, T | 1 |
| Gomita, Y | 1 |
| Yamazaki, M | 1 |
| Suzuki, S | 1 |
| Ozaki, N | 1 |
| Hong, JS | 2 |
| Tilson, HA | 2 |
| Uphouse, LL | 1 |
| Gerhart, J | 1 |
| Wilson, WE | 1 |
| Fernando, JC | 1 |
| Hoskins, BH | 1 |
| Ho, IK | 1 |
| Mohanty, S | 1 |
| Ganguly, DK | 1 |
| Nagao, T | 1 |
| Ohshimo, T | 1 |
| Mitsunobu, K | 1 |
| Sato, M | 1 |
| Otsuki, S | 1 |
| Cox, B | 1 |
| Tha, SJ | 1 |
| Oelszner, W | 1 |
| Funk, KF | 1 |
| Staib, AH | 1 |
| Westermann, KH | 1 |
| Dohi, T | 1 |
| Tsujimoto, A | 1 |
| Growdon, JH | 1 |
| Lenman, JA | 1 |
| Turnbull, MJ | 1 |
| Reid, A | 1 |
| Fleming, AM | 1 |
| McLellan, DL | 1 |
| Chalmers, RJ | 1 |
| Johnson, RH | 1 |
| Squires, RF | 1 |
| Lassen, JB | 1 |
| García Ruiz, PJ | 1 |
| Mena, MA | 1 |
| Peñafiel, N | 1 |
| De Yébenes, JG | 1 |
| Ray, SK | 1 |
| Poddar, MK | 1 |
| Wieland, S | 1 |
| Kreider, MS | 1 |
| McGonigle, P | 1 |
| Lucki, I | 1 |
| Nagata, R | 1 |
| Izumi, K | 1 |
| Hudson, PM | 1 |
| Coppen, A | 1 |
| Metcalfe, M | 1 |
| Carroll, JD | 1 |
| Morris, JG | 1 |
| Peters, DA | 1 |
| Hrdina, PD | 1 |
| Singhal, RL | 1 |
| Ling, GM | 1 |
| Tourian, AY | 1 |
| Curzon, G | 3 |
| Johannsson, B | 1 |
| Roos, BE | 1 |
| Guilleminault, C | 1 |
| Tharp, BR | 1 |
| Cousin, D | 1 |
| Chase, TN | 1 |
| Woods, AC | 1 |
| Glaubiger, GA | 1 |
| Parkes, JD | 1 |
| Marsden, CD | 1 |
| Rees, JE | 1 |
| Kantamaneni, BD | 2 |
| Knill-Jones, R | 1 |
| Akbar, A | 1 |
| Das, S | 1 |
| Kataria, M | 1 |
| Claveria, LE | 1 |
| Harrison, MJ | 1 |
4 trials available for hydroxyindoleacetic acid and Tremor
| Article | Year |
|---|---|
Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Chorea; Clinical Trials as Topic; Confusion; Dioxoles; Dopamine; Drug Ev | 1975 |
Levodopa and L-tryptophan therapy in Parkinsonism.
Topics: Aged; Depression; Dihydroxyphenylalanine; Female; Gait; Homovanillic Acid; Humans; Hydroxyindoleacet | 1972 |
Administration of 5-hydroxy-L-tryptophan to individuals with Huntington's chorea.
Topics: 5-Hydroxytryptophan; Adult; Brain; Evaluation Studies as Topic; Female; Humans; Huntington Disease; | 1972 |
Parkinson disease treated with a suspected dopamine receptor agonist.
Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Dihydroxyphenyla | 1974 |
28 other studies available for hydroxyindoleacetic acid and Tremor
| Article | Year |
|---|---|
6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Central Nervous System Stimulants; Cereb | 2012 |
Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzodiazepines; Cerebral Cortex; Dopamine; Flumazenil; GAB | 2013 |
RETRACTED: Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Axons; Brain; Carrier Proteins; Corpus Str | 2002 |
Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice.
Topics: Animals; Behavior, Animal; Brain Chemistry; Cerebellum; Chromatography, High Pressure Liquid; Dopami | 2003 |
Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; | 2004 |
Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Binding Sites; | 2008 |
Biochemical investigation on the abnormal behaviors induced by fumitremorgin A, a tremorgenic mycotoxin to mice.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Hydroxyindoleacetic Acid; Indenes; Male; Mice; Se | 1983 |
Effects of chlordecone exposure on brain neurotransmitters: possible involvement of the serotonin system in chlordecone-elicited tremor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Brain Chemistry; Chlordecone; Corpus Stri | 1984 |
A striatal serotonergic involvement in the behavioural effects of anticholinesterase organophosphates.
Topics: Animals; Atropine; Behavior, Animal; Cholinesterase Inhibitors; Corpus Striatum; Drug Interactions; | 1984 |
Neonatal treatment with 5-HT antiserum alters 5-HT metabolism and function in adult rats.
Topics: Animals; Animals, Newborn; Basal Ganglia; Brain; Hydroxyindoleacetic Acid; Immune Sera; Pain; Rats; | 1995 |
Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Topics: Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Ho | 1979 |
Amantadin e tremor, a 5-hydroxytryptamine-mediated response?
Topics: Amantadine; Animals; Brain; Brain Chemistry; Fenclonine; Hydroxyindoleacetic Acid; Mice; Mice, Inbre | 1975 |
Serotonin content in the central nervous system of rats and cholinergic tremor.
Topics: Animals; Brain; Brain Chemistry; Female; Fenclonine; Hydroxyindoleacetic Acid; Oxotremorine; Parasym | 1975 |
Possible mechanisms of sustained tremor induction by nicotine in pilocarpine treated animals.
Topics: Animals; Brain; Corpus Striatum; Dopamine; Fenclonine; Hemicholinium 3; Homovanillic Acid; Hydroxyin | 1978 |
Postural changes, tremor, and myoclonus in the rat immediately following injections of p-chloromaphetamine.
Topics: Amphetamines; Animals; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Male; Motor Activ | 1977 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; | 1977 |
The inhibition of A and B forms of MAO in the production of a characteristic behabioural syndrome in rats after 1-tryptophan loading.
Topics: Alkynes; Animals; Brain Chemistry; Clorgyline; Drug Synergism; Humans; Hydroxyindoleacetic Acid; Hyp | 1975 |
Cinnarizine-induced parkinsonism in primates.
Topics: Animals; Biogenic Monoamines; Cinnarizine; Disease Models, Animal; Dopamine; Haplorhini; Homovanilli | 1992 |
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bro | 1990 |
Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature Regulation; Brain; Dose-Response R | 1990 |
Veratramine-induced behavior associated with serotonergic hyperfunction in mice.
Topics: 5,6-Dihydroxytryptamine; Animals; Brain Chemistry; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbre | 1991 |
5,5-Diphenylhydantoin antagonizes neurochemical and behavioral effects of p,p'-DDT but not of chlordecone.
Topics: Animals; Brain Chemistry; Brain Stem; Caudate Nucleus; Chlordecone; DDT; Hippocampus; Hydroxyindolea | 1986 |
The role of brain serotonin in DDT-induced hyperpyrexia.
Topics: Animals; Brain; Brain Stem; DDT; Fenclonine; Fever; Fluorine; Hydroxyindoleacetic Acid; Male; Pargyl | 1972 |
Involuntary movements other than Parkinsonism: biochemical aspects.
Topics: Acute Disease; Animals; Athetosis; Basal Ganglia; Brain; Dopamine; Fecal Incontinence; Homovanillic | 1973 |
5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; Cerebellar Ataxia; Cerebrovascular Disorder | 1974 |
HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Chorea; Dopamine; Dystonia Musculorum Deformans; Femal | 1973 |
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
Topics: Aged; Dementia; Dihydroxyphenylalanine; Electroencephalography; Female; Gait; Homovanillic Acid; Hum | 1974 |
Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis.
Topics: Cerebellar Diseases; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Multiple Sclerosis; Phenyl | 1974 |